The false-negative rate of sentinel lymph node biopsy and its related factors in early-stage cervical cancer: a systematic review and meta-analysis

Authors

  • Chao He Department of Obstetrics and Gynecology, Lequn Branch, The First Hospital of Jilin University, Changchun, Jilin Province, China.
  • Fei Li Department of Obstetrics and Gynecology, Lequn Branch, The First Hospital of Jilin University, Changchun, Jilin Province, China.
  • Min He Department of Obstetrics and Gynecology, Lequn Branch, The First Hospital of Jilin University, Changchun, Jilin Province, China.
  • Jia Li Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin Province, China

DOI:

https://doi.org/10.2340/1651-226X.2026.44984

Abstract

Background and purpose: The objective of this systematic review and meta-analysis was to evaluate the false-negative rate (FNR) of sentinel lymph node biopsy (SLNB) performed in patients with early-stage cervical cancer (ECC), and to study the risk factors affecting FNR.
Material and methods: We searched three databases (Embase, MEDLINE, and Cochrane Central Library) for articles published in the last decade from January 2014 to September 2024. Publications on patients with ECC who underwent SLNB, with information on the FNR of SLNB, were included. The QUADAS-2 tool was used to assess the risk of bias and the clinical applicability of the included studies. The FNR and associated factors were synthesized using random-effects meta-analysis and meta-regression.
Results: A total of 49 eligible studies with a low to moderate risk of bias were included in the final analysis. The overall FNR was 10.9% (95 CI: 6.0–16.7). No significant differences in FNR were found for different reference standards or tumor diameters (< 2 cm vs. ≥ 2 cm). However, different tracers (e.g. methylene blue [MB], carbon nanoparticle [CNP], indocyanine green [ICG], and Technetium-99m [Tc-99m] combined with other tracers) appear to account for the different FNRs. In the meta-regression analysis, we found that the proportion of SLNs located in the obturator area was significantly negatively associated with FNR (coefficient = −0.88, p = 0.04).
Interpretation: The overall FNR of SLNB for ECC was approximately 10.9%. Factors that tended to reduce the FNR included using a low-volume metastatic detection technique, having a tumor diameter of < 2 cm, employing specific tracer regimens, and identifying more than one lymph node in the obturator fossa.
Registration: PROSPERO (CRD42024608411)

 

Downloads

Download data is not yet available.

References

Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.

https://doi.org/10.1001/archsurg.1992.01420040034005 DOI: https://doi.org/10.1001/archsurg.1992.01420040034005

Nieweg OE, Uren RF, Thompson JF. The history of sentinel lymph node biopsy. Cancer J. 2015;21:3–6.

https://doi.org/10.1097/PPO.0000000000000091 DOI: https://doi.org/10.1097/PPO.0000000000000091

Chen SL, Iddings DM, Scheri RP, Bilchik AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin. 2006;56:292–309; quiz 16–7.

https://doi.org/10.3322/canjclin.56.5.292 DOI: https://doi.org/10.3322/canjclin.56.5.292

Gipponi M. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms. Minerva Chir. 2005;60:217–33.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

https://doi.org/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660

Guani B, Gaillard T, Teo-Fortin LA, Balaya V, Feki A, Paoletti X, et al. Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: cervical cancer application. Front Oncol. 2022;12:935628.

https://doi.org/10.3389/fonc.2022.935628 DOI: https://doi.org/10.3389/fonc.2022.935628

Olthof EP, van der Aa MA, Adam JA, Stalpers LJA, Wenzel HHB, van der Velden J, et al. The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review. Int J Clin Oncol. 2021;26:1600–10.

https://doi.org/10.1007/s10147-021-01980-2 DOI: https://doi.org/10.1007/s10147-021-01980-2

Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018;379:1905–14.

https://doi.org/10.1056/NEJMoa1804923 DOI: https://doi.org/10.1056/NEJMoa1804923

Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895–904.

https://doi.org/10.1056/NEJMoa1806395 DOI: https://doi.org/10.1056/NEJMoa1806395

Guani B, Dorez M, Magaud L, Buenerd A, Lecuru F, Mathevet P. Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial. Int J Gynecol Cancer. 2019;29:447–52.

https://doi.org/10.1136/ijgc-2018-000089 DOI: https://doi.org/10.1136/ijgc-2018-000089

Martin-Hirsch P, Wood N, Whitham NL, Macdonald R, Kirwan J, Anagnostopoulos A, et al. Survival of women with early-stage cervical cancer in the UK treated with minimal access and open surgery. BJOG. 2019;126:956–9.

https://doi.org/10.1111/1471-0528.15617 DOI: https://doi.org/10.1111/1471-0528.15617

Gianoni M, Mathevet P, Uzan C, Bats AS, Magaud L, Boutitie F, et al. Does the sentinel lymph node sampling alone improve quality of life in early cervical cancer management? Front Surg. 2020;7:31.

https://doi.org/10.3389/fsurg.2020.00031 DOI: https://doi.org/10.3389/fsurg.2020.00031

Balaya V, Guani B, Pache B, Durand YG, Bonsang-Kitzis H, Ngô C, et al. Sentinel lymph node in cervical cancer: time to move forward. Chin Clin Oncol. 2021;10:18.

https://doi.org/10.21037/cco-21-5 DOI: https://doi.org/10.21037/cco-21-5

Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – update 2023. Virchows Arch. 2023;482:935–66.

https://doi.org/10.1007/s00428-023-03552-3 DOI: https://doi.org/10.1007/s00428-023-03552-3

Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, et al. NCCN Guidelines® Insights: cervical cancer, Version 1.2024. J Natl Compr Canc Netw. 2023;21:1224–33.

https://doi.org/10.6004/jnccn.2023.0062 DOI: https://doi.org/10.6004/jnccn.2023.0062

Wang L, Liu S, Xu T, Yuan L, Yang X. Sentinel lymph node mapping in early-stage cervical cancer: meta-analysis. Medicine (Baltimore). 2021;100:e27035.

https://doi.org/10.1097/MD.0000000000027035 DOI: https://doi.org/10.1097/MD.0000000000027035

Margioula-Siarkou C, Almperis A, Gullo G, Almperi EA, Margioula-Siarkou G, Nixarlidou E, et al. Sentinel lymph node staging in early-stage cervical cancer: a comprehensive review. J Clin Med. 2023;13(1):27. DOI: https://doi.org/10.3390/jcm13010027

https://doi.org/10.20944/preprints202310.0828.v1 DOI: https://doi.org/10.20944/preprints202310.0828.v1

Ronsini C, De Franciscis P, Carotenuto RM, Pasanisi F, Cobellis L, Colacurci N. The oncological implication of sentinel lymph node in early cervical cancer: a meta-analysis of oncological outcomes and type of recurrences. Medicina (Kaunas). 2022;58(11):1539.

https://doi.org/10.3390/medicina58111539 DOI: https://doi.org/10.3390/medicina58111539

Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: current limitations and unanswered questions. Gynecol Oncol. 2019;152:202–7.

https://doi.org/10.1016/j.ygyno.2018.10.007 DOI: https://doi.org/10.1016/j.ygyno.2018.10.007

Salib MY, Russell JHB, Stewart VR, Sudderuddin SA, Barwick TD, Rockall AG, et al. 2018 FIGO staging classification for cervical cancer: added benefits of imaging. RadioGraphics. 2020;40:1807–22.

https://doi.org/10.1148/rg.2020200013 DOI: https://doi.org/10.1148/rg.2020200013

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

https://doi.org/10.1136/bmj.n71 DOI: https://doi.org/10.1136/bmj.n71

Saleh M, Virarkar M, Javadi S, Elsherif SB, de Castro Faria S, Bhosale P. Cervical cancer: 2018 revised international federation of gynecology and obstetrics staging system and the role of imaging. Am J Roentgenol. 2020;214:1182–95.

https://doi.org/10.2214/AJR.19.21819 DOI: https://doi.org/10.2214/AJR.19.21819

Fan MS, Qiu KX, Wang DY, Wang H, Zhang WW, Yan L. Risk factors associated with false negative rate of sentinel lymph node biopsy in endometrial cancer: a systematic review and meta-analysis. Front Oncol. 2024;14:1391267.

https://doi.org/10.3389/fonc.2024.1391267 DOI: https://doi.org/10.3389/fonc.2024.1391267

Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: a review. JAMA. 2023;330:547–58.

https://doi.org/10.1001/jama.2023.13174 DOI: https://doi.org/10.1001/jama.2023.13174

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.

https://doi.org/10.7326/0003-4819-155-8-201110180-00009 DOI: https://doi.org/10.7326/0003-4819-155-8-201110180-00009

Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11:193–206. DOI: https://doi.org/10.1037/1082-989X.11.2.193

Ioannidis JP. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008;14:951–7.

https://doi.org/10.1111/j.1365-2753.2008.00986.x DOI: https://doi.org/10.1111/j.1365-2753.2008.00986.x

Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046–55. DOI: https://doi.org/10.1016/S0895-4356(01)00377-8

Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16:195–203.

https://doi.org/10.1097/XEB.0000000000000141 DOI: https://doi.org/10.1097/XEB.0000000000000141

Zhang Z, Chang Q. Clinical analysis of sentinel lymph node identification in patients with cervical cancer. Eur J Gynaecol Oncol. 2014;35:26–31.

Bats AS, Frati A, Froissart M, Orliaguet I, Querleu D, Zerdoud S, et al. Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL study. Ann Nucl Med. 2015;29:63–70.

https://doi.org/10.1007/s12149-014-0910-1 DOI: https://doi.org/10.1007/s12149-014-0910-1

de Freitas RR, Baiocchi G, Hatschbach SBB, Linhares JC, Guerreiro JA, Minari CL, et al. Can a sentinel node mapping algorithm detect all positive lymph nodes in cervical cancer? Ann Surg Oncol. 2015;22:1564–9.

https://doi.org/10.1245/s10434-014-4245-x DOI: https://doi.org/10.1245/s10434-014-4245-x

Imboden S, Papadia A, Nauwerk M, McKinnon B, Kollmann Z, Mohr S, et al. A comparison of radiocolloid and indocyanine green fluorescence imaging, sentinel lymph node mapping in patients with cervical cancer undergoing laparoscopic surgery. Ann Surg Oncol. 2015;22:4198–203. DOI: https://doi.org/10.1245/s10434-015-4701-2

Kato H, Ohba Y, Yamazaki H, Minobe S-I, Sudo S, Todo Y, et al. Availability of tissue rinse liquid-based cytology for the rapid diagnosis of sentinel lymph node metastasis and improved bilateral detection by photodynamic eye camera. Jpn J Clin Oncol. 2015;45:727–31.

https://doi.org/10.1093/jjco/hyv079 DOI: https://doi.org/10.1093/jjco/hyv079

Buda A, Crivellaro C, Elisei F, Di Martino G, Guerra L, De Ponti E, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer (99m)Tc and/or blue dye. Ann Surg Oncol. 2016;23:2183–91.

https://doi.org/10.1245/s10434-015-5022-1 DOI: https://doi.org/10.1245/s10434-015-5022-1

Cibula D, Zikan M, Slama J, Fischerova D, Kocian R, Germanova A, et al. Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer. Gynecol Oncol. 2016;143:83–6.

https://doi.org/10.1016/j.ygyno.2016.07.101

Cusimano MC, Walker R, Bernardini MQ, Bouchard-Fortier G, Laframboise S, May T, et al. Implementing a cervical sentinel lymph node biopsy program: quality improvement in gynaecologic oncology. J Obstet Gynaecol Canada. 2017;39:659–67. DOI: https://doi.org/10.1016/j.jogc.2017.02.017

https://doi.org/10.1016/j.ygyno.2016.07.101 DOI: https://doi.org/10.1016/j.ygyno.2016.07.101

Deng X, Zhang Y, Li D, Zhang X, Guo H, Wang F, et al. Abdominal radical trachelectomy guided by sentinel lymph node biopsy for stage IB1 cervical cancer with tumors >2 cm. Oncotarget. 2017;8:3422–9. DOI: https://doi.org/10.18632/oncotarget.13788

Di Martino G, Crivellaro C, De Ponti E, Bussi B, Papadia A, Zapardiel I, et al. Indocyanine green versus radiotracer with or without blue dye for sentinel lymph node mapping in stage >IB1 cervical cancer (>2 cm). J Minim Invasive Gynecol. 2017;24:954–9.

https://doi.org/10.1016/j.jmig.2017.05.011 DOI: https://doi.org/10.1016/j.jmig.2017.05.011

Lu Y, Wei J-Y, Yao D-S, Pan Z-M, Yao Y. Application of carbon nanoparticles in laparoscopic sentinel lymph node detection in patients with early-stage cervical cancer. PLoS One. 2017;12:e0183834.

https://doi.org/10.1371/journal.pone.0183834 DOI: https://doi.org/10.1371/journal.pone.0183834

Papadia A, Gasparri ML, Genoud S, Bernd K, Mueller MD. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer. J Cancer Res Clin Oncol. 2017;143:2275–81.

https://doi.org/10.1007/s00432-017-2467-6 DOI: https://doi.org/10.1007/s00432-017-2467-6

Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, et al. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017;145:96–101.

https://doi.org/10.1016/j.ygyno.2017.02.005 DOI: https://doi.org/10.1016/j.ygyno.2017.02.005

Tanaka T, Terai Y, Ashihara K, Tsunetoh S, Akagi H, Yamada T, et al. The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye. J Gynecol Oncol. 2017;28:e13. DOI: https://doi.org/10.3802/jgo.2017.28.e13

Buda A, Papadia A, Di Martino G, Imboden S, Bussi B, Guerra L, et al. Real-time fluorescent sentinel lymph node mapping with indocyanine green in women with previous conization undergoing laparoscopic surgery for early invasive cervical cancer: comparison with radiotracer +/- blue dye. J Minim Invasive Gynecol. 2018;25:455–60.

https://doi.org/10.1016/j.jmig.2017.10.002 DOI: https://doi.org/10.1016/j.jmig.2017.10.002

Cea Garcia J, de la Riva Perez PA, Rodriguez Jimenez I, Marquez Maraver F, Polo Velasco A, Jimenez Gallardo J, et al. Selective biopsy of the sentinel node in cancer of cervix: experience in validation phase. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018;37:359–65. DOI: https://doi.org/10.1016/j.remnie.2018.07.002

https://doi.org/10.1016/j.remn.2018.04.003 DOI: https://doi.org/10.1016/j.remn.2018.04.003

Kim J-H, Kim D-Y, Suh D-S, Kim J-H, Kim Y-M, Kim Y-T, et al. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer. World J Surg Oncol. 2018;16:52.

https://doi.org/10.1186/s12957-018-1341-6 DOI: https://doi.org/10.1186/s12957-018-1341-6

Soergel P, Kirschke J, Klapdor R, Derlin T, Hillemanns P, Hertel H. Sentinel lymphadenectomy in cervical cancer using near infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid. Lasers Surg Med. 2018;50:994–1001.

https://doi.org/10.1002/lsm.22999 DOI: https://doi.org/10.1002/lsm.22999

Sonoda K, Yahata H, Okugawa K, Kaneki E, Ohgami T, Yasunaga M, et al. Value of intraoperative cytological and pathological sentinel lymph node diagnosis in fertility-sparing trachelectomy for early-stage cervical cancer. Oncology. 2018;94:92–8. DOI: https://doi.org/10.1159/000484049

Yahata H, Kobayashi H, Sonoda K, Kodama K, Yagi H, Yasunaga M, et al. Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer. Int J Clin Oncol. 2018;23:1167–72.

https://doi.org/10.1007/s10147-018-1327-y DOI: https://doi.org/10.1007/s10147-018-1327-y

Diaz-Feijoo B, Temprana-Salvador J, Franco-Camps S, Manrique S, Colas E, Perez-Benavente A, et al. Clinical management of early-stage cervical cancer: the role of sentinel lymph node biopsy in tumors <=2cm. Eur J Obstet Gynecol Reprod Biol. 2019;241:30–4.

https://doi.org/10.1016/j.ejogrb.2019.07.038 DOI: https://doi.org/10.1016/j.ejogrb.2019.07.038

Balaya V, Guani B, Benoit L, Magaud L, Bonsang-Kitzis H, Ngo C, et al. Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging. Gynecol Oncol. 2020;158:576–83.

https://doi.org/10.1016/j.ygyno.2020.05.043 DOI: https://doi.org/10.1016/j.ygyno.2020.05.043

Bizzarri N, Pedone Anchora L, Zannoni GF, Santoro A, Valente M, Inzani F, et al. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer. Int J Gynecol Cancer. 2020;30:364–71.

https://doi.org/10.1136/ijgc-2019-000939 DOI: https://doi.org/10.1136/ijgc-2019-000939

Dostalek L, Slama J, Fisherova D, Kocian R, Germanova A, Fruhauf F, et al. Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer. Int J Gynecol Cancer. 2020;30:744–8.

https://doi.org/10.1136/ijgc-2019-001113 DOI: https://doi.org/10.1136/ijgc-2019-001113

Favre G, Guani B, Balaya V, Magaud L, Lecuru F, Mathevet P. Sentinel lymph-node biopsy in early-stage cervical cancer: the 4-year follow-up results of the Senticol 2 trial. Front Oncol. 2020;10:621518.

https://doi.org/10.3389/fonc.2020.621518 DOI: https://doi.org/10.3389/fonc.2020.621518

Gil-Ibanez B, Glickman A, Del Pino M, Boada D, Fuste P, Diaz-Feijoo B, et al. Vaginal fertility-sparing surgery and laparoscopic sentinel lymph node detection in early cervical cancer. Retrospective study with 15 years of follow-up. Eur J Obstet Gynecol Reprod Biol. 2020;251:23–7.

https://doi.org/10.1016/j.ejogrb.2020.05.039 DOI: https://doi.org/10.1016/j.ejogrb.2020.05.039

Luhrs O, Ekdahl L, Lonnerfors C, Geppert B, Persson J. Combining Indocyanine Green and Tc99-nanocolloid does not increase the detection rate of sentinel lymph nodes in early stage cervical cancer compared to Indocyanine Green alone. Gynecol Oncol. 2020;156:335–40.

https://doi.org/10.1016/j.ygyno.2019.11.026 DOI: https://doi.org/10.1016/j.ygyno.2019.11.026

Papathemelis T, Scharl A, Anapolski M, C Inwald E, Ignatov A, Ortmann O, et al. Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancer. Arch Gynecol Obstet. 2020;301:787–92.

https://doi.org/10.1007/s00404-020-05457-x DOI: https://doi.org/10.1007/s00404-020-05457-x

Rychlik A, Angeles MA, Migliorelli F, Croce S, Mery E, Martinez A, et al. Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer. Int J Gynecol Cancer. 2020;30:358–63.

https://doi.org/10.1136/ijgc-2019-000904 DOI: https://doi.org/10.1136/ijgc-2019-000904

Santoro A, Angelico G, Inzani F, Arciuolo D, Spadola S, Valente M, et al. Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer. Int J Gynecol Cancer. 2020;30:1871–7.

https://doi.org/10.1136/ijgc-2020-001710 DOI: https://doi.org/10.1136/ijgc-2020-001710

Wang Y, Dan Z, Yuan G, Zhang G, Liu S, Zhang Y, et al. Detection of sentinel lymph node in laparoscopic surgery for uterine cervical cancer using carbon nanoparticles. J Surg Oncol. 2020;122:934–40.

https://doi.org/10.1002/jso.26100 DOI: https://doi.org/10.1002/jso.26100

Bjornholt SM, Sponholtz SE, Markauskas A, Froding LP, Larsen CR, Fuglsang K, et al. Sentinel lymph node mapping for endometrial and cervical cancer in Denmark. Dan Med J. 2021;68.

Diniz TP, Faloppa CC, Mantoan H, Goncalves BT, Kumagai LY, Menezes ANO, et al. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer. J Surg Oncol. 2021;123:1115–20.

https://doi.org/10.1002/jso.26341 DOI: https://doi.org/10.1002/jso.26341

Harano N, Sakamoto M, Fukushima S, Iwai S, Koike Y, Horikawa S, et al. Clinical study of sentinel lymph node detection using photodynamic eye for abdominal radical trachelectomy. Curr Oncol (Toronto, Ont). 2021;28:4709–20.

https://doi.org/10.3390/curroncol28060397 DOI: https://doi.org/10.3390/curroncol28060397

Sponholtz SE, Mogensen O, Hildebrandt MG, Schledermann D, Parner E, Markauskas A, et al. Sentinel lymph node mapping in early-stage cervical cancer – a national prospective multicenter study (SENTIREC trial). Gynecol Oncol. 2021;162:546–54.

https://doi.org/10.1016/j.ygyno.2021.06.018 DOI: https://doi.org/10.1016/j.ygyno.2021.06.018

Weissinger M, Taran F-A, Gatidis S, Kommoss S, Nikolaou K, Sahbai S, et al. Lymph node staging with a combined protocol of 18F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO I/II cervical carcinoma. J Nucl Med. 2021;62:1062–7.

https://doi.org/10.2967/jnumed.120.255919 DOI: https://doi.org/10.2967/jnumed.120.255919

Ya X, Qian W, Huiqing L, Haixiao W, Weiwei Z, Jing B, et al. Role of carbon nanoparticle suspension in sentinel lymph node biopsy for early-stage cervical cancer: a prospective study. BJOG. 2021;128:890–8. DOI: https://doi.org/10.1111/1471-0528.16504

Aoki Y, Kanao H, Fusegi A, Omi M, Okamoto S, Tanigawa T, et al. Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer. Int J Clin Oncol. 2022;27:1499–506.

https://doi.org/10.1007/s10147-022-02197-7 DOI: https://doi.org/10.1007/s10147-022-02197-7

Baeten IGT, Hoogendam JP, Braat AJAT, Zweemer RP, Gerestein CG. Feasibility of a drop-in gamma-probe for radioguided sentinel lymph detection in early-stage cervical cancer. EJNMMI Res. 2022;12:36. DOI: https://doi.org/10.1186/s13550-022-00907-w

Devaja O, Papadopoulos AJ, Bharathan R, Montalto SA, Coutts M, Tan A, et al. Sentinel lymph node biopsy alone in the management of early cervical carcinoma. Int J Gynecol Cancer. 2022;32:15–20.

https://doi.org/10.1136/ijgc-2019-001082 DOI: https://doi.org/10.1136/ijgc-2019-001082

Luhrs O, Bollino M, Ekdahl L, Lonnerfors C, Geppert B, Persson J. Similar distribution of pelvic sentinel lymph nodes and nodal metastases in cervical and endometrial cancer. A prospective study based on lymphatic anatomy. Gynecol Oncol. 2022;165:466–71.

https://doi.org/10.1016/j.ygyno.2022.03.027 DOI: https://doi.org/10.1016/j.ygyno.2022.03.027

Niu G, Ren Y, Zhai Y. Association study between the sentinel lymph node biopsy and the clinicopathological features of patients with cervical cancer. Dis Markers. 2022;2022:9697629.

https://doi.org/10.1155/2022/9697629 DOI: https://doi.org/10.1155/2022/9697629

Smits A, Ten Eikelder M, Dhanis J, Moore W, Blake D, Zusterzeel P, et al. Finding the sentinel lymph node in early cervical cancer: when is unusual not uncommon? Gynecol Oncol. 2023;170:84–92.

https://doi.org/10.1016/j.ygyno.2022.12.013 DOI: https://doi.org/10.1016/j.ygyno.2022.12.013

Amengual Vila J, Torrent Colomer A, Sampol Bas C, Quintero Duarte A, Ruiz Coll M, Rioja Merlo J, et al. Detecting atypical sentinel lymph nodes in early-stage cervical cancer using a standardized technique with a hybrid tracer. Cancers. 2024;16:2626.

https://doi.org/10.3390/cancers16152626 DOI: https://doi.org/10.3390/cancers16152626

Bizzarri N, Fedele C, Teodorico E, Certelli C, Pedone Anchora L, Carbone V, et al. Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer. Eur J Surg Oncol. 2024;50:108250.

https://doi.org/10.1016/j.ejso.2024.108250 DOI: https://doi.org/10.1016/j.ejso.2024.108250

Bizzarri N, Querleu D, Ramirez PT, Dostalek L, van Lonkhuijzen LRW, Giannarelli D, et al. Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: a sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study. Eur J Cancer. 2024;211:114310.

https://doi.org/10.1016/j.ejca.2024.114310 DOI: https://doi.org/10.1016/j.ejca.2024.114310

Bogani G, Scambia G, Fagotti A, Fanfani F, Ciavattini A, Sopracordevole F, et al. Sentinel node mapping, sentinel node mapping plus back-up lymphadenectomy, and lymphadenectomy in Early-sTage cERvical caNcer scheduled for fertilItY-sparing approach: the ETERNITY project. Eur J Surg Oncol. 2024;50:108467.

https://doi.org/10.1016/j.ejso.2024.108467 DOI: https://doi.org/10.1016/j.ejso.2024.108467

Persson J, Luhrs O, Geppert B, Ekdahl L, Lonnerfors C. A prospective study evaluating an optimized sentinel node algorithm in early stage cervical cancer: the PROSACC-study. Gynecol Oncol. 2024;187:178–83.

https://doi.org/10.1016/j.ygyno.2024.05.019 DOI: https://doi.org/10.1016/j.ygyno.2024.05.019

Vemula Venkata VL, Hulikal N, Chowhan AK. Effectiveness of sentinel lymph node biopsy and bilateral pelvic nodal dissection using methylene blue dye in early-stage operable cervical cancer – a prospective study. Cancer Treat Res Commun. 2024;39:100816.

https://doi.org/10.1016/j.ctarc.2024.100816 DOI: https://doi.org/10.1016/j.ctarc.2024.100816

Cheng-Yen Lai J, Yang MS, Lu KW, Yu L, Liou WZ, Wang KL. The role of sentinel lymph node biopsy in early-stage cervical cancer: a systematic review. Taiwan J Obstet Gynecol. 2018;57:627–35.

https://doi.org/10.1016/j.tjog.2018.08.003 DOI: https://doi.org/10.1016/j.tjog.2018.08.003

Frumovitz M, Ramirez PT, Levenback CF. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008;110:S17–20.

https://doi.org/10.1016/j.ygyno.2008.03.012 DOI: https://doi.org/10.1016/j.ygyno.2008.03.012

Bianchi T, Grassi T, Di Martino G, Negri S, Trezzi G, Fruscio R, et al. Low-volume metastases in cervical cancer: does size matter? Cancers (Basel). 2024;16(6):1107. DOI: https://doi.org/10.3390/cancers16061107

https://doi.org/10.20944/preprints202402.1586.v1 DOI: https://doi.org/10.20944/preprints202402.1586.v1

Wang XJ, Fang F, Li YF. Sentinel-lymph-node procedures in early stage cervical cancer: a systematic review and meta-analysis. Med Oncol. 2015;32:385.

https://doi.org/10.1007/s12032-014-0385-x DOI: https://doi.org/10.1007/s12032-014-0385-x

Agustí N, Viveros-Carreño D, Mora-Soto N, Ramírez PT, Rauh-Hain A, Wu CF, et al. Diagnostic accuracy of sentinel lymph node frozen section analysis in patients with early-stage cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2023;177:157–64.

https://doi.org/10.1016/j.ygyno.2023.08.019 DOI: https://doi.org/10.1016/j.ygyno.2023.08.019

Guani B, Mahiou K, Crestani A, Cibula D, Buda A, Gaillard T, et al. Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: a comprehensive meta-analysis. Gynecol Oncol. 2022;164:446–54.

https://doi.org/10.1016/j.ygyno.2021.12.015 DOI: https://doi.org/10.1016/j.ygyno.2021.12.015

Rocco N, Velotti N, Pontillo M, Vitiello A, Berardi G, Accurso A, et al. New techniques versus standard mapping for sentinel lymph node biopsy in breast cancer: a systematic review and meta-analysis. Updates Surg. 2023;75:1699–710.

https://doi.org/10.1007/s13304-023-01560-1 DOI: https://doi.org/10.1007/s13304-023-01560-1

Nagar H, Wietek N, Goodall RJ, Hughes W, Schmidt-Hansen M, Morrison J. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer. Cochrane Database Syst Rev. 2021;6:Cd013021.

https://doi.org/10.1002/14651858.CD013021.pub2 DOI: https://doi.org/10.1002/14651858.CD013021.pub2

Zhang X, Bao B, Wang S, Yi M, Jiang L, Fang X. Sentinel lymph node biopsy in early stage cervical cancer: a meta-analysis. Cancer Med. 2021;10:2590–600.

https://doi.org/10.1002/cam4.3645 DOI: https://doi.org/10.1002/cam4.3645

Additional Files

Published

2026-03-16

How to Cite

He, C., Li, F., He, M., & Li, J. (2026). The false-negative rate of sentinel lymph node biopsy and its related factors in early-stage cervical cancer: a systematic review and meta-analysis. Acta Oncologica, 65, 213–227. https://doi.org/10.2340/1651-226X.2026.44984